Gilead Sciences, Inc.

About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines in areas of unmet medical need. Established in 1987, Gilead has made significant contributions to the treatment of various diseases, particularly in the fields of HIV/AIDS, liver diseases, cancer, inflammatory diseases, and respiratory conditions.

The company is renowned for its commitment to advancing healthcare through scientific innovation and research. Gilead’s portfolio includes several groundbreaking therapies that have transformed the lives of patients worldwide. The company operates with a vision to improve patient outcomes by providing access to high-quality medicines.

• Core Areas of Focus: Gilead’s primary focus areas include antiviral drugs, oncology, and inflammation.
• Global Reach: With operations in over 30 countries, Gilead aims to address global health challenges and expand access to its therapies.
• Research and Development: Gilead invests heavily in R&D, collaborating with academic institutions and other organizations to foster innovation.

In addition to its therapeutic advancements, Gilead is dedicated to corporate social responsibility, engaging in initiatives that support public health and community well-being. The company strives to ensure that its medicines are accessible to those who need them most, regardless of their geographical location or economic status.

With a strong pipeline of potential new therapies, Gilead Sciences, Inc. continues to lead the way in biopharmaceutical innovation, driven by a mission to enhance the quality of life for patients around the globe.